Text and Data Mining valid from 2019-09-21
First Online: 21 September 2019
Compliance with Ethical Standards
: No sources of funding or writing assistance were received for the preparation of this Article.
: Michael Kurin declares no conflict of interest. Ronnie Fass serves as an advisor to Ironwood, Takeda and Chinoin, speaker for Astrazeneca, Takeda Horizon Cadilla Pharmaceuticals, Diversitek and Eisai, and has received research support from Ironwood and Salix.